sulfamethoxazole has been researched along with Red-Cell Aplasia, Pure in 2 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Red-Cell Aplasia, Pure: Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stricker, RB | 1 |
| Goldberg, B | 1 |
| Unter, CE | 1 |
| Abbott, GD | 1 |
2 other studies available for sulfamethoxazole and Red-Cell Aplasia, Pure
| Article | Year |
|---|---|
AIDS and pure red cell aplasia.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; HIV-1; Humans; Red-Cell Aplasia, Pure; Su | 1997 |
Co-trimoxazole red cell aplasia in leukaemia.
Topics: Anti-Infective Agents; Child, Preschool; Drug Combinations; Humans; Leukemia, Lymphoid; Male; Pneumo | 1987 |